# Combination Therapy for Chronic Hepatitis C Infection

> **NCT01805882** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 229 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **DRUG:** Sofosbuvir
- **DRUG:** Ledipasvir
- **DRUG:** GS-9669
- **DRUG:** GS-9451

## Key facts

- **NCT ID:** NCT01805882
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 229 (ACTUAL)
- **Last updated:** 2017-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01805882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01805882, "Combination Therapy for Chronic Hepatitis C Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01805882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*